高级检索
当前位置: 首页 > 详情页

Prognostic role of SCAMP family in acute myeloid leukemia

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, 510260 Guangzhou, China [2]Translational Medicine Center, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, 510260 Guangzhou, China [3]Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands [4]Department of Biomedical Sciences, University of Sassari, Sassari, Italy [5]Translational Medicine Center, Huaihe Hospital of Henan University, 475000 Kaifeng, China [6]Department of Hematology, Huaihe Hospital of Henan University, 475000 Kaifeng, China [7]Department of Operations and Information Management, China- Japan Friendship Hospital, 100029 Beijing, China [8]Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, 310058 Hangzhou, China [9]Department of Biomedical Engineering, Chinese PLA General Hospital, 100853 Beijing, China
出处:
ISSN:

摘要:
Acute myeloid leukemia (AML) is a malignant disease of myeloid hematopoietic stem or progenitor cells characterized by abnormal proliferation of primary and immature myeloid cells in bone marrow and peripheral blood. Gene mutation and expression profiles can be used as prognosis predictors for different prognostic subgroups. Secretory carrier-associated membrane proteins (SCAMPs) are a multigenic family with five members and act as cell surface vectors in the post-Golgi recycling pathways in mammals. Nevertheless, the prognostic and clinical influence of SCAMP family has hardly ever been illustrated in AML. In our study, expression patterns of SCAMP family (SCAMP1-5) were analyzed in 155 AML patients which were extracted from the Cancer Genome Atlas database. In chemotherapy, only subgroup, higher SCAMP1 level was significantly associated with longer EFS and OS (all P = 0.002), and SCAMP1 was confirmed to be an independent favorable factor in un-transplanted patients by Multivariate analysis (all P < 0.05). Nevertheless, in the allogeneic hematopoietic stem cell transplantation (allo-HSCT) treatment subgroup, none of the SCAMP genes had any effect on the clinical survival. Our study found that high expression level of SCAMP1 is a favorable prognostic factor in AML, but allo-HSCT may neutralize its prognostic effect.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 药学 3 区 遗传学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 遗传学 3 区 药学
JCR分区:
出版当年[2018]版:
Q2 PHARMACOLOGY & PHARMACY Q2 GENETICS & HEREDITY
最新[2023]版:
Q2 GENETICS & HEREDITY Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2018版] 出版当年五年平均[2014-2018] 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, 510260 Guangzhou, China [2]Translational Medicine Center, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, 510260 Guangzhou, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, 510260 Guangzhou, China [2]Translational Medicine Center, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, 510260 Guangzhou, China [5]Translational Medicine Center, Huaihe Hospital of Henan University, 475000 Kaifeng, China [6]Department of Hematology, Huaihe Hospital of Henan University, 475000 Kaifeng, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)